[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"repair-of-dura-mater\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:repair-of-dura-mater":91},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,37,55,73],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":36},"100621474",false,"NCT07371091","Post-market Clinical Investigation Plan: Collagen Dura Regeneration Membrane - Repair (DMR)","Monitoring the Use of Collagen Dura Membrane - Repair (DMR) in the Post-market Phase","Inclusion Criteria:\n\n* Patients with a dural defect requiring repair with a dural substitute as per routine clinical practice\n* Patient is 18 years or older\n* Patient of child-bearing potential is not pregnant or nursing\n* Participant is willing and able to provide consent\n\nExclusion Criteria:\n\n* Patients with a known history of hypersensitivity to bovine derived materials\n* Patients that are non-English speaking\n* Patients requiring legal representation","ALL","18 Years",{"count":18,"type":19},110,"ESTIMATED","OBSERVATIONAL","Monitoring the Use of Collagen Dura Regeneration Membrane - Repair (DMR) in the Post-market Phase.",[23],"Repair of Dura Mater","NOT_YET_RECRUITING","2026-05-27",{"date":27,"type":28},"2026-05-29","ACTUAL",{"date":30,"type":19},"2026-07",{"date":32,"type":19},"2027-12",{"name":34,"class":35},"Collagen Matrix","INDUSTRY",2,{"id":38,"slug":4,"hasResults":10,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":4,"eligibilityCriteria":42,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":43,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":41,"conditions":45,"keywords":4,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":36},"100577733","NCT06802133","Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)","Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.","Inclusion Criteria:\n\n* The general population will be included in the study where a dura substitute is required for the repair of dura mater.\n\nExclusion Criteria:\n\n* Patients that have conditions which are contraindicated per the instructions for use (IFU) would be excluded.",{"count":44,"type":19},118,[23],"RECRUITING","2025-10-14",{"date":49,"type":28},"2025-10-15",{"date":51,"type":28},"2025-01-13",{"date":53,"type":19},"2026-07-30",{"name":34,"class":35},{"id":56,"slug":4,"hasResults":10,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":4,"eligibilityCriteria":60,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":61,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":63,"conditions":64,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},"100609634","NCT07217132","Clinical Investigation Plan - Post-market Clinical Follow-up Study Collagen Dura Membrane - Suturable","Monitoring the Use of Collagen Dura Membrane - Suturable (DMS) in the Post-market Phase","Inclusion Criteria:\n\n* Patients with a dural defect requiring repair with a dural substitute\n* Patient is 18 years or older\n* Patient of child-bearing potential is not pregnant or nursing\n\nExclusion Criteria:\n\n* Patients with a known history of hypersensitivity to bovine derived materials\n* Patients that are non-English speaking\n* Subjects requiring Legally Authorized Representative",{"count":62,"type":19},54,"Monitoring the use of Collagen Dura Membrane - Suturable (DMS) in the post-market phase",[23],"2025-10-13",{"date":49,"type":28},{"date":68,"type":19},"2025-12-01",{"date":70,"type":19},"2027-09",{"name":34,"class":35},1,{"id":74,"slug":4,"hasResults":10,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":80,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":81,"conditions":82,"keywords":4,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":72},"100579332","NCT06822920","Post-Market Clinical Investigation Plan - Collagen Dura Membranes (DM & DMO)","Monitoring the Use of Collagen Dura Membrane in the Post-market Phase","DM&DMO","Inclusion Criteria:\n\n* Patients with a dural defect requiring repair with a dural substitute.\n\nExclusion Criteria:\n\n* There are no subject restrictions for the study other than patients with known allergy to bovine collagen products as specified in the contraindications of the Instructions for Use.",{"count":18,"type":19},"Monitoring the Use of Collagen Dura Membrane in the Post-market phase",[23],"2025-02-07",{"date":85,"type":28},"2025-02-12",{"date":87,"type":28},"2025-01-03",{"date":89,"type":19},"2025-12-30",{"name":34,"class":35},""]